American Heart Journal
Volume 148, Issue 3 , Pages 422-429, September 2004

A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effect☆

  • John G. Webb, MD

      Affiliations

    • Divisions of Cardiology and Nephrology and the Pharmacy Department, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    • Corresponding Author InformationReprint requests: John G. Webb, MD, Director of Cardiac Catheterization, St. Paul's Hospital, Room 5202A, 1081 Burrard St, Vancouver, British Columbia, Canada V6Z 1Y6.
    • ,
  • Gordon E. Pate, MB, MSc

      Affiliations

    • Divisions of Cardiology and Nephrology and the Pharmacy Department, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Karin H. Humphries, MBA, DSc

      Affiliations

    • Divisions of Cardiology and Nephrology and the Pharmacy Department, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Christopher E. Buller, MD

      Affiliations

    • Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Stephen Shalansky, PharmD

      Affiliations

    • Divisions of Cardiology and Nephrology and the Pharmacy Department, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Ali Al Shamari, MD

      Affiliations

    • Divisions of Cardiology and Nephrology and the Pharmacy Department, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Anton Sutander, MD

      Affiliations

    • Divisions of Cardiology and Nephrology and the Pharmacy Department, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Tracey Williams

      Affiliations

    • Divisions of Cardiology and Nephrology and the Pharmacy Department, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Rebecca S. Fox, MSc

      Affiliations

    • Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Adeera Levin, MD

      Affiliations

    • Divisions of Cardiology and Nephrology and the Pharmacy Department, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada

Received 7 November 2003; accepted 30 March 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported in part by Tyco Canada Inc, Shiley Canada Inc, Vancouver Hospital Interventional Trust, and the St Paul's Hospital Foundation.

PII: S0002-8703(04)00187-5

doi:10.1016/j.ahj.2004.03.041

American Heart Journal
Volume 148, Issue 3 , Pages 422-429, September 2004

Article Tools

* Image Usage & Resolution